DiscoverThe Orange Pill PodcastEpisode 62- NMN is Back: Inside the FDA’s Reversal on a Top Anti-Aging Ingredient
Episode 62- NMN is Back: Inside the FDA’s  Reversal on a Top Anti-Aging Ingredient

Episode 62- NMN is Back: Inside the FDA’s Reversal on a Top Anti-Aging Ingredient

Update: 2025-10-07
Share

Description

After nearly three years of uncertainty, the FDA has officially reversed its stance on Nicotinamide Mononucleotide (NMN), the popular anti-aging compound once banned from supplement shelves.


In this episode, we unpack the twists and turns that led to the agency’s dramatic U-turn, the key legal reinterpretation that changed everything, and how relentless industry advocacy forced the FDA’s hand.


From Citizen Petitions to regulatory chaos, discover what really happened behind the scenes, and why this win for NMN could foreshadow the next big battle in dietary supplement regulation.


Tune in to understand the future of NMN, the gaps still left unaddressed, and what this means for innovation in the supplement industry.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 62- NMN is Back: Inside the FDA’s  Reversal on a Top Anti-Aging Ingredient

Episode 62- NMN is Back: Inside the FDA’s Reversal on a Top Anti-Aging Ingredient

KGK Science